Huntington’s Disease
Huntington’s disease, also known as Huntington’s chorea, is a hereditary neurodegenerative disorder that affects both the brain and the body. It is named after Dr. George Huntington, who first described the condition in the late 19th century.
Huntington’s disease is caused by a genetic mutation in the huntingtin gene (HTT), which leads to the production of abnormal huntingtin protein. The mutation involves an abnormal repetition of the CAG trinucleotide within the gene, causing an expansion of the repeating sequence. The more repeats a person has, the earlier and more severe the onset of the disease tends to be.
This magazine contains content which is gathered, validated, categorized, and supplied using a novel big data cyberinfrastructure technology that continually learns about Huntington’s Disease.
-
Publication date: Apr 18, 2025 DNAJ proteins, also known as HSP40s, are co-chaperones that regulate ...
-
Oxytocin Anti-Apoptotic Potential Mediates Neuroprotection Against 3-Nitropropionic Acid-Induced Huntington’s Disease-Like Pathophysiology in Rats: Involvement of Calpain-2/p25 Cdk5/MEF-2 Signaling Pathway.
Publication date: Apr 19, 2025 The increasing interest in the pro-apoptotic function of calpain-2 in ... -
Developmental, neuroanatomical and cellular expression of genes causing dystonia
Publication date: Apr 17, 2025 Objective Dystonia is one of the most common forms of ... -
Functional Rating Scale 2.0 (FuRST 2.0): A patient-reported outcome measure of function for Huntington’s disease.
Publication date: Apr 15, 2025 BackgroundCurrent functional rating scales are not sensitive to the earliest ... -
Functional Rating Scale 2.0 (FuRST 2.0): A patient-reported outcome measure of function for Huntington’s disease.
Publication date: Apr 15, 2025 BackgroundCurrent functional rating scales are not sensitive to the earliest ... -
The role of Panax ginseng in neurodegenerative disorders: mechanisms, benefits, and future directions.
Publication date: Apr 15, 2025 Neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), ... -
The role of Panax ginseng in neurodegenerative disorders: mechanisms, benefits, and future directions.
Publication date: Apr 15, 2025 Neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), ... -
Huntingtin-interacting protein 1 in cancer progression: a path less explored.
Publication date: Apr 15, 2025 Huntingtin-interacting protein 1 (HIP1) is a multi-domain heterodimeric protein mainly ... -
Huntingtin-interacting protein 1 in cancer progression: a path less explored.
Publication date: Apr 15, 2025 Huntingtin-interacting protein 1 (HIP1) is a multi-domain heterodimeric protein mainly ... -
Inhibitor-based modulation of huntingtin aggregation mechanisms mitigates fibril-induced cellular stress.
Publication date: Apr 15, 2025 Huntington’s disease (HD) is a neurodegenerative disorder in which mutated ... -
Inhibitor-based modulation of huntingtin aggregation mechanisms mitigates fibril-induced cellular stress.
Publication date: Apr 15, 2025 Huntington’s disease (HD) is a neurodegenerative disorder in which mutated ... -
-
Knockouts for the win: how expanding CAGs drive disease
Publication date: Apr 15, 2025 In fact, this group used statistics to define the rate ... -
Knockouts for the win: how expanding CAGs drive disease
Publication date: Apr 15, 2025 In fact, this group used statistics to define the rate ... -
Knockouts for the win: how expanding CAGs drive disease
Publication date: Apr 15, 2025 In fact, this group used statistics to define the rate ... -
Communicating Genetic Information in Families with Inherited Late-Onset Neurodegenerative Diseases: A Scoping Review.
Publication date: Mar 26, 2025 Communicating genetic information within families living with inherited genetic conditions ... -
The Art of Neuroregeneration De Novo and In Situ.
Publication date: Mar 26, 2025 Neuroregeneration refers to the ability of the nervous system to ... -
The Art of Neuroregeneration De Novo and In Situ.
Publication date: Mar 26, 2025 Neuroregeneration refers to the ability of the nervous system to ... -
Deutetrabenazine treatment outcomes with doses above U.S. Food and Drug Administration maximum approved doses in Huntington’s disease chorea: A dual-site analysis.
Publication date: Mar 23, 2025 BackgroundDeutetrabenazine, a vesicular monoamine transporter 2 inhibitor, is one of ... -
Unraveling Berberine’s Molecular Mechanisms in Neuroprotection against Neurodegeneration.
Publication date: Mar 24, 2025 Neurodegenerative diseases (NDs) exhibit significant global public health challenges due ... -
Use of Paliperidone Long-Acting Injections in Huntington’s Disease.
Publication date: Mar 25, 2025 Concepts Keywords Disease Acting Drugs Clin Huntington Disease Long Drugs ...